The importance of fecal calprotectin in the diagnostics and treatment of inflammatory bowel diseases von Letkovský, Juraj, Hlavatý, Tibor

Volltext

Biosimilars in the therapy of inflammatory bowel diseases von Hlavaty, Tibor, Letkovsky, Juraj

Volltext

Biosimilar infliximab CT-P13 treatment in patients with inflammatory bowel diseases – a one-year, single-centre retrospective study von Hlavatý, Tibor, Krajčovičová, Anna, Šturdík, Igor, Letkovský, Juraj, Koller, Tomáš, Tóth, Jozef, Huorka, Martin

Volltext

Delayed hypersensitivity reaction after initial dose of infliximab: a case report von Krajcovicova, Anna, Hlavaty, Tibor, Zelinkova, Zuzana, Letkovsky, Juraj, Huorka, Martin

Volltext

Combination therapy with an immunomodulator and anti-TNFα agent improves bone mineral density in IBD patients von Krajcovicova, Anna, Hlavaty, Tibor, Killinger, Zdenko, Miznerova, Ema, Toth, Jozef, Letkovsky, Juraj, Nevidanska, Monika, Cierny, Daniel, Koller, Tomas, Zelinkova, Zuzana, Huorka, Martin, Payer, Juraj

Volltext

Sa1256 Combined Immunosuprpession, Corticoids and Menopause Have Significant Influcence on Bone Mineral Density in IBD Patients. A Prospective Study von Krajcovicova, Anna, Hlavaty, Tibor, Killinger, Zdenko, Miznerova, Ema, Toth, Jozef, Cierny, Daniel, Koller, Tomas, Letkovsky, Juraj, Zelinkova, Zuzana, Huorka, Martin, Payer, Juraj

Volltext